
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CIPLc1:NS | NSE | INR | Delayed | |
CIPLc2:NS | NSE | INR | Delayed | |
CIPLc3:NS | NSE | INR | Delayed |
On Tuesday, UBS maintained its Buy rating on Cipla Ltd. (CIPLA:IN) shares but reduced the price target from INR2,060.00 to INR1,960.00. The adjustment comes in light of the anticipated impact on...
Global financial services firm UBS initiated coverage on Cipla Ltd. (CIPLA: IN), an Indian multinational pharmaceutical company, with a Buy rating. The firm has set a price target for Cipla at...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review